Interstitial lung disease (ILD) is frequently associated with collagen diseases, and is designated collagen vascular disease-associated ILD (CVD-ILD) that influences the prognosis of the disease. Acute-onset diffuse ILD (AoDILD) occurs in patients with collagen disease with or without underlying CVD-ILD. The prognosis of AoDILD is quite poor. It has been reported that plasma amino acid profiles are altered in rheumatoid arthritis (RA) patients. Here, we investigated the plasma amino acid profiles to determine whether they may be useful for diagnosing CVD-ILD or AoDILD in collagen disease.
Interstitial lung disease (ILD) is characterized by interstitial inflammation of the lung and frequently associated with collagen diseases including rheumatoid arthritis (RA), systemic lupus erythematosus, systemic sclerosis (SSc), polymyositis/dermatomyositis (PM/DM), and polyarteritis nodosa. ILD associated with collagen diseases is then designated collagen vascular disease-associated ILD (CVD-ILD). CVD-ILD is one of the major manifestations of collagen disease and influences the prognosis of collagen disease.
Plasma Amino Acid Profiles in Collagen Disease Patients with Interstitial Lung Disease: Hiroshi Furukawa, Shomi Oka, Kenji Takehana, Takahiko Muramatsu, Kota Shimada, Akiko Komiya, Naoshi Fukui, Naoyuki Tsuchiya and Shigeto Tohma
Journal of Pulmonary & Respiratory Medicine welcomes articles related to "lung diseases"
Last date updated on November, 2020